Policy | December 20, 2023
Norms for fixing prices of medicines
NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201
NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201
Clariant Healthcare highlighted Vitipure Meglumine LEX and VitiPure Superior at the recently concluded CPhI India
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
The products are slated to be manufactured at the Ankleshwar facility and is expected to start contributing meaningfully to the revenue from FY25
10+ emerging markets, Japan & ANZ transition in final phase
This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment
Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services
Leading USA based genetic testing brand officially enters the Indian market
The CVMP recommends the product for approval for the treatment and persistent killing of fleas
New facility is part of Aptar Pharma’s global expansion program
Subscribe To Our Newsletter & Stay Updated
